Immunogenic compositions for use in pneumococcal vaccines
US10653764B2 · kind B2 · utility
6Cited by
12References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 5, 2016 |
| Grant date | May 19, 2020 |
| Priority date | — |
| Expiry date | Jan 5, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/70
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An object of the present invention is to provide immunogenic compositions for protection against S. pneumoniae, in particular against S. pneumoniae serogroup 9, while limiting the number of conjugates. The present invention thereforerelates to new immunogenic compositions for use in pneumococcal vaccines and to vaccination of human subjects, in particular infants and elderly, against pneumoccocal infections using said immunogenic compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.